Press Releases

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that the company will present at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held Oct. 26-30, 2019, in Boston. The presentation will inclu

ATLANTA, Oct. 16, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 third quarter financial results will be released on Wednesday, October 30, 2019 after the market closes. On that day, the Company will hold a teleconference call and live webca

FLINT, Mich., Oct. 16, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), effective today, has completed the sale of certain assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC, a multifaceted healthcare communication center. Financial details and additional terms of the transaction were not disclosed.

MIAMI, Oct. 16, 2019 /PRNewswire/ -- The Issa Trust Foundation, the non-profit organization of Couples Resorts Jamaica, announced today it raised $30,000(USD) in support of Bahamian relief efforts. The donation will provide direct medical assistance to people in need through Issa Trust Foundation partners Direct Relief and Heart to Heart Int

RALEIGH, N.C., Oct. 16, 2019 /PRNewswire/ -- Orthus Health, an innovative wellness provider, is proud to announce the appointment of Andrea Coviello, MD, FACE, MMCi, MSc of Duke University as the company's Medical Advisor. Dr. Coviello is board-certified in Internal Medicine, Endocrinology, Diabetes and Me

CHICAGO, Oct. 16, 2019 /PRNewswire/ -- CareBand, Inc. announces it has been awarded National Institutes of Health (NIH) Phase I Small Business Innovation Research funding to determine

LA JOLLA, Calif., Oct. 16, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceut

LOS ANGELES, Oct. 16, 2019 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC), today announced that pursuant to an Order of the Superior Court of California, County of Los Angeles, entered on October 3, 2019, in the matter of David Wiener, derivativ

WASHINGTON, Oct. 16, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients, urges federal agencies, particularly the U.S. Food and Drug Administration (FDA), to comply with the

DUBLIN, Oct. 16, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m.